Relmada Therapeutics, Inc. RLMD Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $730.04M.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s market capitalization?
- Relmada Therapeutics, Inc. (RLMD) reported market capitalization of $730.04M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s market capitalization changed year-over-year?
- Relmada Therapeutics, Inc.'s market capitalization increased by 8046.1% year-over-year, from $8.96M to $730.04M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s market capitalization has grown at a -16.8% compound annual growth rate (CAGR), from $889.18M to $354.2M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.